Vycor Medical, Inc.
VYCO
$0.0679
-$0.0001-0.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 455.20K | 390.90K | 406.30K | 337.00K | 308.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 455.20K | 390.90K | 406.30K | 337.00K | 308.20K |
| Cost of Revenue | 57.80K | 36.80K | 35.20K | 37.00K | 42.00K |
| Gross Profit | 397.40K | 354.10K | 371.10K | 300.00K | 266.20K |
| SG&A Expenses | 356.50K | 367.90K | 337.80K | 294.60K | 313.70K |
| Depreciation & Amortization | 14.90K | 14.90K | 14.90K | 14.90K | 14.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 435.90K | 426.00K | 390.10K | 346.50K | 372.30K |
| Operating Income | 19.30K | -35.10K | 16.20K | -9.50K | -64.10K |
| Income Before Tax | -6.70K | -59.80K | -10.00K | -30.50K | -90.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.70K | -59.80K | -10.00K | -30.50K | -90.00K |
| Earnings from Discontinued Operations | -100.00 | 0.00 | 0.00 | -100.00 | -3.10K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.70K | -59.80K | -10.00K | -30.60K | -93.10K |
| EBIT | 19.30K | -35.10K | 16.20K | -9.50K | -64.10K |
| EBITDA | 36.20K | -19.40K | 31.90K | 6.10K | -49.00K |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 33.38M | 32.90M | 32.63M | 32.63M | 32.63M |
| Average Diluted Shares Outstanding | 33.38M | 32.90M | 32.63M | 32.63M | 32.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |